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Abstract
Objectives—Little is known about blood cholesterol (blood-C) levels under conditions of
infection and limited diet. This study examines blood-C and markers of infection and
inflammation in the Tsimane of the Bolivian Amazon, indigenous forager farmers living in
conditions that model preindustrial European populations by their short life expectancy, high load
of infections and inflammation, and limited diets.
Methods—We use multivariate models to determine the relationships between lipid levels and
markers of infection and inflammation. Adult Tsimane (N = 418, age 20–84) were characterized
for blood lipids, cells, and inflammatory markers in relation to individual loads of parasites and
village region.
Results—Most of the Tsimane (60%) carried at least one parasite species, averaging 1.3 species
per person. Serum high-density lipoprotein cholesterol (HDL-C), total cholesterol (total-C), and
low-density lipoprotein cholesterol (LDL-C) were below the U.S. norms and varied inversely with
markers of infection and inflammation: C-reactive protein (CRP), interleukin-6 (IL-6), erythrocyte
sedimentation rate (ESR), immunoglobulin (Ig) E and eosinophil count. Although no relationship
of parasite load to blood-C was found, there was an association between anemia and parasite
prevalence.
Conclusions—We conclude that the highly infected environment of the Tsimane is related to
low levels of blood total-C, HDL-C, and LDL-C. This may suggest a potential reason why arterial
disease is largely absent in the Tsimane.
The Tsimane, forager farmers of the Bolivian Amazon, are a model for aging in
preindustrial human populations because of their short lifespans, high infectious morbidity,
variable energy balance with high workloads, natural high fertility (Walker et al., 2008), and
limited access to modern medicine. Mortality throughout the lifespan has been high; until
recently, their life expectancy at birth of 42.8 years (1950–1989) approximates the
demographics of 19th century European populations, Sweden, for example (Gurven et al.,
2007, 2008; McDade et al., 2005).
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In addition to short life expectancies, the Tsimane also exhibit relatively low levels of blood
cholesterol (blood-C) (Vasunilashorn et al., 2010; additional data presented here). Although
these low lipid levels may be attributed to their typically modest diets with low saturated fat,
the Tsimane also have high levels of infection. We predict that in high-infection
environments there would be a potential inverse relationship between markers of infection
and inflammation and blood lipid levels.
The Tsimane have a high prevalence of elevated blood C-reactive protein (CRP) at all ages
(Gurven et al., 2008; McDade et al., 2007), about 25% having a CRP value greater than 10
mg/dl, a level that indicates acute or chronic infections. In modern industrial nations with
longer life expectancy and a lower burden of infection, high levels of CRP (≥3.0 mg/dl) are
considered indicators of cardiovascular risk (Danesh et al., 1998; Ridker et al., 2009).
Tsimane reaching their 43-year life expectancy have experienced twice the average number
of years cumulatively lived with high CRP (≥3.0 mg/dl) above the United States (Gurven et
al., 2008).
Blood lipids are important mediators of host defense during the acute phase of innate
immunity. Infection and inflammation typically lower blood total cholesterol (total-C) and
high density lipoprotein cholesterol (HDL-C), but increase triglycerides (Esteve et al., 2005;
Finch, 2007; Jahangiri et al., 2009; Khovidhunkit et al., 2004; McGullicuddy et al., 2009).
Several types of infections—viral, bacterial, and parasitic—have been linked to blood lipid
levels. Viral infection, as in human immunodeficiency virus (HIV) infections, are associated
with lower blood levels of total-C and HDL-C (Anastos et al., 2007; Riddler et al., 2007;
Rose et al., 2006), with a greater degree of dyslipidemia associated with greater immune
suppression (Constans et al., 1994; Grunfeld et al., 1992; Zangerle et al., 1994). Among
those infected with HIV and taking antiviral therapy, total-C, and in some cases, HDL-C
was increased (Rimland et al., 2006). Experimental inflammation from bacterial endotoxin
(lipopolysaccharide, LPS) induces similar dyslipidemias (McGullicuddy et al., 2009). The
hypocholesterolemia and remodeling of lipoproteins during acute phase responses of innate
immunity increases clearance of LPS, particularly through increased binding of LPS to HDL
particles (Kitchens and Thompson, 2003; Levels et al., 2007), is one example.
Specific parasitic infections also cause dyslipidemias. A study of the Shipibo, another
indigenous Amazonian group, showed an inverse correlation of HDL-C with the density of
infection by three of five parasitic worm species (N =32) (Wiedermann et al., 1991).
Similar-sized samples from a city hospital in Chandigarh, India, showed lower HDL-C for
patients with entamoebic and giardia parasites (Bansal et al., 2005). A novel hypothesis
linking parasitic infection to cardiovascular disease (CVD) risk is that parasitic worms
(helminths) may attenuate atherosclerosis through interactions with host defense systems
(Magen et al., 2005). This relationship may involve several mechanisms. First, the helminths
can suppress the host immune response through production of antiinflammatory molecules,
thereby reducing the risk of CVD. Second, parasitic worms may lower the LDL levels both
directly and indirectly: via regulating innate antibodies to cholesterol and interfering with
host nutrition (respectively). About one third of LDL turnover is attributed to the effects of
these naturally occurring antibodies to cholesterol (Alving and Wassef, 1999; Caspar-
Bauguil et al., 1999; Folcik et al., 1997). Moreover, infections potentially elicited by
parasites may also regulate host lipid metabolism by stimulating a decrease in total-C levels
(Doenhoff et al., 2002).
Nutrition has long been associated with blood-C levels (Clarke et al., 1997). Generally,
greater intake of saturated fatty acids has been associated with higher levels of serum
cholesterol (C) (Mattson et al., 1972). In subsistence populations, where food containing
high saturated fats is less available than in modern societies, C levels are lower. For
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instance, blood-C was below the U.S. norms in several indigenous African populations and
Trobiand Islanders (Expert Panel on Detection Evaluation, and Treatment of High Blood
Cholesterol in Adults, 2001; Lindeberg et al., 2003; Pauletto et al., 1996; Pavan et al., 1997),
and total-C levels of hunter gatherers were about 125 mg/dl (Eaton et al., 1988).
Another reason for suspecting that inflammatory markers and parasite burden may be
associated with lower C among the Tsimane is that in populations with low energy balance
and fat reserves, the burden of disease may reduce available energy further, thus affecting
circulating C. Considered together, we predict that in high-infection environments there
would be inverse relationships between the markers of infection and inflammation and blood
lipid levels.
This study extends the previous studies on the separate effects of viral, bacterial, and
parasitic infections. We considered that analyzing a combination of these types of infections
could further clarify the links to blood lipids. We examined the relationships of blood lipid
levels to markers of (1) inflammation [CRP and interleukin-6 (IL-6)], (2) the general burden
of infection [erythrocyte sedimentation rate (ESR) and white blood cell count (WBC) and
distribution], and (3) specific infections [parasite prevalence and indicators of parasite
prevalence, including WBC subtype eosinophil count and immunoglobulin (Ig) E]. We also
examine the body mass index (BMI), stunting, and location of village in relation to cultural
influences from the nearest town, San Borja.
This article tests the hypothesis that the Tsimane, with a high infectious load, will exhibit
relatively low lipid levels; thereby indicating an inverse relationship between infection and
cholesterol. We hypothesize that lower levels of blood lipids will be associated with lower
levels of past nutrition (i.e., lower BMI) and that blood-C levels will be higher in the more
acculturated village regions located near San Borja.
METHODS
Study Sample
This study sample was drawn from the Tsimane Life History and Health Project (Gurven et
al., 2008), which has been examining health across the life course since 2002. Interviews,
medical examinations, and blood were collected from 17 communities across the traditional
Tsimane territories. Blood and feces were sampled in 2004. This forager farmer population,
of about 7,000, has low caloric intake relative to energy expenditure and consequently low
BMI. The Tsimane provide a model for preindustrial human populations with limited food
supply, high energy expenditure, no sanitation systems, no water treatment, and limited
medical intervention (Byron, 2003; Reyes-Garcia et al., 2008; Vadez et al., 2004).
Table 1 summarizes the Tsimane adult sample (N = 418) for this analysis. The present study
was restricted to individuals aged 20 and older (range: 20–84), with blood and fecal samples
taken in 2004. Because Tsimane villages have different access to markets and medical care
that may affect C and infections, we categorized the Tsimane communities into three
geographic regions (Supporting Information Fig. 1) (Gurven et al., 2007): more acculturated
villages near the town of San Borja; villages in the interior forest; and remote villages along
the upper Maniqui River. These categorizations also reflect the differences in diet; for
example, the Maniqui River villagers obtain more food from fish, while those in the forests
obtain food from hunting. The Tsimane do not have regular exposure to modern medicines;
however, those living closer to San Borja have more access to health care and richer diets,
which are indicated by differences in stunting and underweight (Table 1). We include region
as a covariate in the analysis to adjust for differences in access to modern medicine and diet.
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Cholesterol Measures
Blood serum was analyzed for total-C, HDL-C, and low-density lipoprotein cholesterol
(LDL-C). Persons were asked to fast before coming for medical testing, but fasting was not
verified. Cholesterol was stratified into high and low levels associated with adverse health
outcomes in the United States (Table 2): high-risk cutoffs of HDL-C <40 mg/dl, LDL-C
>160 mg/dl, and total-C >240 mg/dl. In ordinary least squares (OLSs) regressions (models
described in further detail later), total-C, HDL-C, and LDL-C were used as continuous
variables.
Measures of Infection and Inflammation
Blood samples were analyzed for CRP [high sensitivity (hs)-CRP], IL-6, ESR, WBC count
and distribution (neutrophils, eosinophils, basophils, monocytes, and lymphocytes), and Igs
A, E, G, and M. CRP is an innate immune system response to acute and chronic infections.
In the U.S. and other populations with low levels of infection, CRP may also be an indicator
of general systemic inflammatory responses due to chronic diseases, including
atherosclerosis and diabetes. IL-6 is a cytokine with broad cellular roles in health and
disease. Serum hs-CRP and IL-6 were determined from samples collected and frozen in the
field, and assayed at 0.1–150.0 mg/l and 2.0–1,000.0 pg/ml (respectively) at the Tricore
Reference Laboratories in Albuquerque, New Mexico using Immulite 2000 kits. The mean
replicate interassay coefficient variation was 5.6% for hs-CRP and 5.8% for IL-6
(Diagnostics Products Corporation, Siemens, Deerfield, IL). Clinically normal ranges and
mean values defined for U.S. populations are shown in Table 3. Using cut points employed
in large-scale epidemiological studies to define low and high levels (Ferrucci et al., 2005;
Seeman et al., 2004), we created an inflammatory score based on levels of both markers
CRP and IL-6 (range, 0–2: 0 = high on neither, high on 1 only, high on both). An alternative
score based on the highest Tsimane tertile for CRP (≥5.23 mg/l) and IL-6 (≥3.02 pg/ml)
yielded similar results in relation to the blood-C measures; thus, the CRP-IL6 score is based
on published cut points.
The ESR (mm/h) gives a nonspecific measure of inflammation (Ingelsson et al., 2005; Sox
and Liang, 1986). For a point of reference, we note that the mean ESR in the United States is
15 mm/h (Gillum et al., 1994; Smith and Samadian, 1994) (Table 3). In our OLS
regressions, ESR is included as sex-specific quintiles (listed at the bottom of Table 4).
Different levels are used for males and females due to gender variations in ESR (Piva et al.,
2001).
The WBC (leukocyte) total count includes information on five types that can indicate the
type of infection: eosinophils, neutrophils, leukocytes, basophils, and monocytes. The
complete blood cell counts were analyzed in the field using fresh samples. Because
eosinophils are elevated in some parasitic infections, the level of eosinophils was included
as a categorical variable by distributing the percentages into quartiles (Q) in OLS regression.
Four different immunoglobulins (Igs) were measured. IgE levels may be associated with
parasitic infection and allergic reactions. IgM is the body’s primary response to infection,
while IgG is the secondary response. IgA antibodies protect body surfaces exposed to
external foreign substances (e.g., ears, eyes, and nose). IgE was included in OLS regressions
because of its relationship to parasite prevalence. Because of the varying sensitivity to high
levels of the assays used in this project, IgE was categorized into <2,000 and ≥2,000 IU/ml
(Barbee et al., 1981), and mean values are not reported (in Table 3) due to the differences in
assay sensitivity.
One fresh fecal sample for each person was analyzed in the field by an experienced medical
technician, who is a trained biochemist from Universidad Autónoma Gabriel René Moreno.
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The technician used a microscope to detect the presence of 17 species of parasites
(Supporting Information Table 1): nine species of protozoans (Balantidium coli, Bastocystis
hominis, Chilomastix mesnili, Entamoeba coli, Entamoeba hartmanni, Entamoeba
histolytica, Giardia lamblia, Iodamoeba butschilii, and Trichomonas hominis) and seven
worm species [roundworms Ascaris lumbricoides, Strongyloide stercoralis; whipworm
Trichuris trichiura; tapeworms Hymenolepis diminuta and Taenia solium (presumably);
pinworm, Enterobus vermicularis; hookworm. To determine parasite prevalence, a
coverslide with a fecal smear is divided into 30 × 30 boxes. The medical technician scans
the coverslide row by row for the presence or absence of any egg, cyst, trophozoite, or larva
(depending on the species). Each coverslide is scanned for parasites twice. The first scan
occurs at a 10× magnification to search for bigger parasites (e.g., Hookworm, Ascaris
lumbricoides, and Balantidium coli). The second scan uses a 40× magnification for smaller
parasites (e.g., protozoas, Giardia lamblia, and Entamoebas). Two slides for each fecal
sample are examined: (1) sample is mixed with a 0.9% saline solution to observe movement
of certain parasites (e.g., Giardia trophozoites); (2) sample is mixed with an iodine solution
to observe the nuclei of amoebas.
Among these parasites, six parasites have been shown to alter blood-C: Ascaris, Trichuris,
Giardia, Hookworm, Strongyloides, and Entamoeba histolytica (Bansal et al., 2005;
Wiedermann et al., 1991). Dummy variables were constructed for the presence of each of
the six parasites; the total number of these six C-related parasites was also examined.
Covariates
Links between blood-C levels and age, sex, and hemoglobin (Hb) levels are also
investigated (Au and Schilling, 1986; Crimmins et al., 2008a,b; Inouye et al., 1999; Mjos et
al., 1977; Oguntibeju, 2003; Wilson et al., 1994). Because childhood infections can stunt
growth by reallocating resources for development to combat infection, we include stunted
height as an indicator of past exposure to infection (Crimmins and Finch, 2006a,b; Finch,
2007; Finch and Crimmins, 2004; Godoy et al., 2009;McDade et al., 2007, 2008). Stunting
is defined using CDC guidelines (Table 1; Center for Disease Control and Prevention,
1998). Current BMI (kg/m2) is an indicator of both past and present diet and health. In the
OLS regressions, BMI is included as population-derived sex-specific Qs. Hb, which is
related to inflammation and infection as well as with lower lipid levels, was included as a
categorical variable based on the sex-specific population Qs. Variable-specific Q ranges are
listed at the bottom of Table 4.
Statistical Analyses
OLS regression was used to determine the associations between blood-C and infection and
inflammation. In predicting blood-C levels, two separate models were run for total-C, HDL-
C, and LDL-C. The first models include age, sex, region, stunting, sex-specific Qs of BMI,
sex-specific Qs of Hb, CRP-IL6 score, sex-specific quintiles of ESR, IgE, eosinophil Qs,
and six parasites associated with blood-C. The second models include all the covariates from
Model I, except a variable, indicating that the total number of C-related parasites was
included instead of the indicators of the six individual, C-related parasites. Analyses used
SAS 9.1 (SAS Institute, Inc., Cary, NC).
RESULTS
The sample (Table 1) was restricted to individuals aged 20 and more; the average age was
40 years (range, 20–84). About half resided in the river region (52%); 19% lived in the
forest villages; and 29% lived near San Borja. About a fifth (21%) were overweight, but few
were underweight or obese (both 3%) or stunted (4%).
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Cholesterol
The distribution of total-C, HDL-C, and LDL-C in the Tsimane, compared with the United
States, overlaps very little, with the Tsimane exhibiting lower levels for all blood-C levels
(Supporting Information Figs. 2–4, respectively). We used data from persons of the same
age in the U.S. National Health and Nutrition Examination Survey 2001–2006, a nationally
representative study of U.S. residents, to compare the distribution of blood lipids to the
Tsimane in a modern and traditional society. Compared with levels of blood-C in the United
States, the mean total-C, HDL-C, and LDL-C levels among Tsimane adults are lower (Table
2).
Only one individual, a 35-year-old female, had a high-risk level of total-C (>240 mg/dl).
None had elevated LDL-C estimated as >160 mg/dl. Nonetheless, about two thirds had
lower HDL-C in the range representing risk for CVD (<40 mg/dl).
Mean Hb levels were normal. Tsimane males and females had an average Hb of 13 and 12
g/dl (respectively), compared with U.S. male and female averages of 15 and 13 g/dl
(respectively) (Table 2). Half of the Tsimane women and 37% men were anemic compared
with 7% of U.S. women and 3% of U.S. men. Fifty-two percent of Tsimane men and 61% of
women with Ascaris were anemic. All men infected with Trichuris had anemia (Supporting
Information Table 1).
Infection and Inflammation
Table 3 lists the means and range for various markers of infection and inflammation in the
Tsimane and United States. For many of these indicators, the Tsimane mean levels exceed
the U.S. clinical norms. About 48% had elevated levels of CRP (≥3 mg/l), 33% had high
IL-6 (≥2.68 pg/ml), and nearly 25% had elevations of both CRP and IL-6. The total WBC
averaged 10,442 cells/mm3, in the upper range of the clinical norm. In contrast, mean WBC
for individuals in the United States without coronary heart disease is 7,500 cells/mm3
(Friedman et al., 1974). Neutrophils, lymphocytes, and eosinophils in the Tsimane
constituted 51%, 28%, and 20% of WBC (respectively) (Table 3); mean Tsimane
lymphocyte percentage (28%) is above the U.S. mean (19%) (Horne et al., 2005). Relative
to U.S. norms, eosinophils were elevated in 97% of Tsimane, with mean values about
fourfold above the U.S. mean (International Still’s Disease Foundation, 2008). ESR was
elevated in about one quarter (>50 mm/h), with Tsimane mean ESR values (35.8 mm/h)
twofold above the U.S. mean (15 mm/h) (Gillum et al., 1994; Smith and Samadian,
1994).Means of all Igs exceeded the U.S. range, with a substantial proportion in the high
range for IgA (23.2%), IgE (94.2%), IgG (69.1%), and IgM (14.9%).
The majority (60%) of fecal samples had at least one of the six C-related parasites; two or
more parasites were carried by 40% and the average number of parasite species per person
was 1.3 (Table 3). The prevalence by species was Hookworm (46.2%), Ascaris lumbricoides
(17.0%), Entamoeba histolytica (7.3%), Strongyloides (7.1%), Trichuris (2.9%), and Giardia
lamblia (1.6%) (Supporting Information Table 1). These prevalence rates approximated
those of other indigenous populations in South America (Baruzzi, 1970; Benefice and
Barral, 1991; Chernela and Thatcher, 1989; Kaplan et al., 1980; Miranda et al., 1998; Santos
et al., 1995; Tanner et al., 2009).
Associations of Cholesterol with Parasitic Infection, Other Markers of Infection and Blood
Inflammatory Markers
In univariate analyses, most blood-C markers vary inversely with levels of infection
(Supporting Information Table 2). Moreover, those in the highest ESR quintile had lower
total-C levels than the lowest quintile; relative to no parasites, those with one or more
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parasites had lower total-C levels. However, there was no significant inverse relationship of
total-C to eosinophil level (%).
The associations of HDL-C with parasitic infection and other markers of infection and blood
inflammatory markers resemble those of total-C (Supporting Information Table 2): lower
HDL-C levels were associated with elevated CRP, IL-6, the composite of high CRP and
IL-6, and ESR quintiles 4 and 5 (compared to quintiles 1 and 2). Additionally, lower HDL-C
was associated with the prevalence of Entamoeba histolytica and Strongyloides, and having
at least one of the six C-related parasites.
For LDL-C, there were no significant relationships between the indicators of infection and
inflammatory markers (Supporting Information Table 2). Only elevated levels of IL-6 were
significantly associated with lower LDL-C levels.
Multivariate Analysis
Markers of infection and blood inflammatory markers were generally associated with lower
total-C, HDL-C, and LDL-C in multivariate analyses (Table 4). Models I and II showed an
inverse relationship of total-C to elevated levels of both CRP and IL-6 (P = 0.02 for both
models), having high IgE (P < 0.01, for both models), being in the highest Q of eosinophils
(P = 0.09 and P = 0.05 for Models I and II, respectively) and in the lowest Q of Hb (P < 0.01
for both models).
Relative to Tsimane near San Borja, residents in the more remote forest region had higher
total-C (P = 0.16 and P = 0.13, Models I and II, respectively). Compared to individuals with
BMI in Q2 and Q3, those in Q4 had higher total-C (P < 0.01 for both models). These
multivariate models could underestimate the total effect of parasite prevalence, which
presumably affects IgE levels and eosinophils.
Age and sex were associated with total-C (P = 0.02 for both models), such that increasing
age was related to higher total-C levels (P = 0.03 and P = 0.02 for Models I and II,
respectively) and females had higher total-C than males (P = 0.02 and P = 0.01,
respectively).
Models I and II also showed an inverse relationship between HDL-C and high levels for
both CRP and IL-6 (P < 0.01 for both models) and being in the lowest Hb Q (P =0.03 and P
= 0.05 for Models I and II, respectively) (Table 4). Akin to total-C, there were no significant
relationships of total-C to parasite prevalence (Model I). Also, similar to the total-C
findings, forest residents had higher HDL-C levels compared with those living near San
Borja (P < 0.01 for both). In comparison to individuals with BMI Q2 and Q3, those in Q1
and Q4 had higher HDL-C levels, although this relationship was significant only for Q1 (P
=0.02 for both models).
Similar to total-C and HDL-C, no relationships of LDL-C to parasite prevalence were
significant (Table 4; Model I). Compared to individuals with BMI in Q2 and Q3, those in
Q4 had significantly higher LDL-C (P = 0.01; Model II); in contrast to females, males had
lower LDL-C levels as well (P < 0.01). Those residing in the forest area also had higher
LDL-C than those living in San Borja (P < 0.01; Model II).
Overall, our regression analyses show that, after adjusting for various covariates, there is a
significant inverse relationship between blood lipid levels and indicators of infection and
inflammation. Of note, however, is the difference in the relationships between control
variables and the different lipids. For instance, sex and BMI are significantly associated with
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total-C and LDL-C, but not to HDL-C. And the village region is only associated with HDL-
C and not to total-C and LDL-C.
DISCUSSION
This study documents the high pathogen load and low blood lipids of the Tsimane and is the
first to investigate multiple indicators of infection and inflammation to blood-C levels in a
highly infected population. The high levels of pathogens are consistent with earlier reports
on the Tsimane, in this locale (McDade et al., 2005; Gurven et al., 2007; Tanner, 2005). We
found that higher levels of infection and inflammation were associated with lower levels of
total-C, HDL-C, and LDL-C. These relationships remained after adjusting for other
variables related to blood-C, including age, sex, nutrition (as indicated by village region and
BMI), past infection (stunting), and Hb.
The lower total-C, HDL-C, and LDL-C in the Tsimane are suggestive of remodeling of the
HDL-C particle during infections. In acute phase responses of innate immunity, HDL is
altered (“acute phase HDL”), including a reduction of HDL-C, decreased antioxidant
activity, and other structural– compositional changes and interactions with inflammatory
proteins (Khovidhunkit et al., 2001, 2004). Experimentally induced inflammation by
endotoxin (LPS) impairs multiple aspects of reverse C transport that are antiatherogenic,
including efflux of blood-C from macrophages to HDL-C (McGullicuddy et al., 2009).
Future studies may characterize the subclasses of HDL-C particles, particularly the
remodeled particles associated with serum amyloid (SAA) that arise during acute phase
responses (McGullicuddy et al., 2009). The low fat diet of the Tsimane (Byron, 2003;
Reyes-Garcia et al., 2008) may also be a factor, because blood-C can be lowered by low
caloric diets or fasting; we adjusted for this variability in caloric intake by including village
region and BMI in the multivariate analysis. Given the interrelatedness of infection and
caloric intake in determining energy balance, it is often difficult to parcel out their
independent effects. The lack of fat reserves may also interact with infectious load in
producing low levels of blood-C. An adaptive response to high-infectious load may be to
divert energy to combat infections.
These results may provide insight into the endogenous adaptive process of energy
regulation. Where the infectious burden is high, the body allocates more energy to immune
responses, both invoking innate and acquired immunity, thereby reducing the available
energy for other activities. The results on HDL-C are particularly interesting in this regard,
as is the relationship of Hb to total-C, hence suggesting that energy limitation is probably
critical here. Some parasitic infections have been shown to cause anemia (e.g., Ascaris
lumbricoides, Trichuris trichiura, Entamoeba histolytica) (Oguntibeju, 2003; Walter et al.,
1997). This may indicate that infection reduces oxygen transport to muscles, possibly
through an adaptive reallocation of energy to immune function. Similarly, presence of
Ascaris and Trichuris in our Tsimane sample was associated with anemia, while the
presence of Entamoeba histolytica or the total number of prevalent parasites was not.
In addition to considering indicators of infection and inflammatory markers, none of the six
C auxotrophic parasites that has been previously associated with lower blood-C was
associated with individual differences in blood-C in our study. This indirectly suggests that
other types of infection, aside from parasitic infection, are important to the relationship
between blood lipid levels and infection. Alternatively, the presence or absence of a specific
parasite might be too crude for detecting the effect on blood-C. If most individuals have
low-level parasitic infection (as shown in Supporting Information Table 1), egg or worm
burden information might more reliably predict blood-C levels. We found that the number of
parasites was a better predictor of blood-C, perhaps because individuals carrying a greater
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number of parasites (or polyparasitism) also may have a greater intensity of infections,
which may explain the differences in effect between our measure of the total number of
parasites and blood-C compared with the relationship between the presence of each
individual parasite and blood-C levels. Moreover, IgE and eosinophil percentage may be a
better indicator of parasitism compared with the presence/absence of parasite measure
employed here; this may be especially true if parasitism is more chronic. Our study,
however, does find a significant inverse relationship between high IgE levels and total-C.
Gender differences in blood-C among the Tsimane are similar to those of other populations,
with males exhibiting lower total-C and LDL-C compared to females (Assman and Schulte,
1987; Kastarinen et al., 1997; Mazzarolo-Cruz et al. 1995; O’Meara et al., 2004; Stern et al.
2000). Proposed reasons that account for these sex differences include intrinsic differences
in biological risk levels and acquired risks due to differences in work, lifestyle, and health
aspects (Waldron, 1983). Increasing blood-C levels with age, as found for total-C in the
Tsimane, have also been reported in studies of populations with low-fat diets (e.g.,
Tarahumara and Guatamalan Indians) (Conner et al., 1978; Mendez et al., 1962; Werner and
Sareen, 1978) as well as high-fat diets (e.g., the United States) (Jacobs et al., 1980; Keys et
al., 1952). Proposed determinants of this increase with age in total-C include increases in
body fatness with age (Berns et al., 1989).
In the present study, modern medications are unlikely to be an important factor, because
until recently these Tsimane populations have had almost no access to modern medicine.
While it is still very limited, it has increased within the past 10 years. Ethnobotanic
knowledge may also be an important variable in these local differences: McDade et al. 2007
showed that the level of maternal ethnobotanic knowledge correlated with Tsimane child
growth and health and could have been similarly employed more by those living in the more
remote villages of the present study, as suggested by a moderate correlation between
mother’s ethnobotanic knowledge and village distance to the nearest commercial center
(0.49, P < 0.001).
This current study has several strengths, particularly the availability of multiple markers of
immune activation and inflammation and parasite prevalence, in addition to evaluations on
blood-C levels, in a unique population. This study sample gave a unique opportunity to
investigate the relationship between living in a high infection environment and blood-C
levels within an indigenous population. While several studies have examined the
relationship of markers of infection and immune activation to blood-C or the relationship
between parasites and blood-C, none has examined the relationships among all of these
indicators in a well-defined indigenous population.
We also note some limitations. These cross-sectional observations without a longitudinal
component do not allow us to evaluate causal effects. We do not know whether specific
infections result in activation of the inflammatory cascade, which in turn may affect blood-
C. Another caveat is the uncertainty of fasting in the blood samples. The observed low LDL-
C thus might be even lower if fasting were complete. When we categorize the individuals
into those with blood samples drawn in the morning (before 12 p.m.—samples likely
reflecting fasting conditions) and in the afternoon (at or after 12 p.m.—samples less likely to
reflect fasting conditions), we find no significant differences in total-C, HDL-C, nor LDL-C
levels (P = 0.16, 0.69, and 0.13, respectively). Also, the limited number of cases and the
nonsignificant results for LDL-C suggests that the reported relationships of the presence of
the three parasites (Ascaris, Strongyloides, and Hookworm) to LDL-C reflects a true
association (power values of 91, 99, and 97%, respectively), but there does not appear to be
enough power to estimate the relationships of LDL-C to other variables. Lastly, our use of
fecal smears to determine parasite prevalence may result in an underestimate of the actual
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parasite load. Depending on the location of the stool from which the slide smear sample was
taken, traces of a prevalent parasite may not have been detected. This would alter the
observed relationships. Using Percoll gradients to concentrate parasites in a small sample of
Tsimane samples, we observed about one additional parasite species per person above the
fecal smears. Another limitation of our measure of parasite prevalence is the single fecal
sample, which may give an inaccurate parasite prevalence. For a subsample (N = 56) with
two fecal samples taken on different dates in 2004, the majority (70%) showed no difference
in the total number of C-associated parasites.
Variations in blood-C show about 35% heritability in North America, Europe, and Japan
(Dahlen et al., 1983; Hegele et al., 1997; Heller et al., 1993; Rao et al., 1982). Genetic
heritabilities for Amerindians enrolled in the Strong Heart Study (North et al., 2003) and
among Mexican Americans (Mitchell et al., 1996) were also found for HDL-C. Among
Yucatan Mayans, polymorphisms in the apolipoprotein AI/CIII/AIV gene cluster were
associated with a lowering of total-C (Ahn et al., 1991). Futhermore, in Mexican Americans
of the San Antonio Family Heart Study, the additive effects of both shared genes and
environments contributed to an inverse relationship between HDL-C and triglycerides
(Mahaney et al., 1995), suggesting that gene/environment interactions underscore a
substantial amount of the variation in blood lipid levels. Genetic analysis for the Tsimane is
planned, and based on previous studies, we expect that accounting for the effects of genetic
differences, the variance in blood-C levels due to some factors (e.g., BMI) will be slightly
reduced.
In summary, we conclude that the highly infected environment of the Tsimane is related to
low levels of blood total-C, HDL-C, and LDL-C. Our recent study examines other vascular
risk factors and potentially related health outcomes, which have provided more insight as to
the immediate and long-term consequences of living under such highly infected
environmental conditions (Gurven et al., 2009). Decreases in ankle brachial index, a
measure for peripheral arterial disease (PAD) diagnosis, was associated with higher ESR
and diastolic blood pressure, suggesting a relationship between cardiovascular risk factors,
PAD, and infection. Moreover, higher ESR is also associated with lower SBP and DBP in
the Tsimane. This study indicates that arterial disease is largely absent in the Tsimane, and
our present study indicates that one mechanism promoting this would be low levels of
blood-C and disease-mediated reductions in blood-C. Moreover, the Tsimane could be an
important population for evaluating the hypothesis that parasitic helminths attenuate
atherosclerosis and CVD risk through interactions with host-defense systems (Magen et al.,
2005). The present samples allow further analysis of a population with limited access to
antibiotics that can alter inflammatory processes of atherogenesis. The Tsimane thus
represent a unique and fleeting opportunity to study relationships of infection, inflammation,
and aging-related conditions under preindustrial conditions similar to those of our ancestral
past in the absence of modern medicine.
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